PPIA participates in the regulation of miRNA and impacts the sensitivity of breast cancer cells to doxorubicin [140] and the knockdown of RUNX, which is involved in the YAP signaling pathway, enhances sensitivity to doxorubicin in breast cancer cells [139]. The gene discussed is PPIA; the disease is breast carcinoma.